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Abstract
Background: Daily HIV antiretroviral pre-exposure prophylaxis (PrEP) is being evaluated in clinical trials among men 
who have sex with men (MSM). However, daily PrEP may not be congruent with sexual exposure profiles of MSM. Here, 
we investigate sex frequency and sex planning to identify and inform appropriate PrEP strategies for MSM.
Methods: We evaluated sex frequency and sex planning in a cohort of HIV-negative MSM in Bangkok, Thailand. Chi-
squared test was used to compare reports of sex on different weekdays; logistic regression was used to identify 
predictors of sex frequency and sex planning.
Results: Of 823 MSM (with a mean age of 28.3 years), 86% reported having sex on two days per week or less, and 65% 
reported their last sex to have been planned. Sex on the weekend (~30%) was more often reported than sex on 
weekdays (~23%). In multivariate analysis, use of alcohol, erectile dysfunction drugs, group sex, sex with a foreigner, 
buying and selling sex, and a history of HIV testing were associated with having sex on three days or more per week. 
Being aged 22 to 29 years, not identifying as homosexual, having receptive anal intercourse, and not engaging in 
group sex were associated with unplanned sex.
Conclusions: Intermittently dosed PrEP (as opposed to daily) may be a feasible HIV prevention strategy and should be 
considered for evaluation in clinical trials. Risk factors for sex frequency and sex planning may help to identify those in 
need for daily PrEP and those who may not be able to take a timely pre-exposure dose.
Background
Despite high levels of knowledge and awareness about the
protective efficacy of condom use against HIV infection,
the HIV incidence among men who have sex with men
(MSM) remains high. Cohort studies among MSM in the
western world consistently show an HIV incidence of 1%
to 2% per year [1]. Similar studies in the developing world
show an HIV incidence of 5% to 8% per year [2,3]. Addi-
tional strategies to prevent HIV infection among MSM
are therefore urgently needed.
Antiretroviral prophylaxis is widely used to prevent
HIV transmission from mother to child, and has been
shown to prevent HIV acquisition in health care workers
following occupational exposure [4]. Consequently, anti-
retroviral prophylaxis has been proposed as an experi-
mental strategy to prevent sexual and parenteral
transmission of HIV infection in humans [5-7]. Studies of
daily pre-exposure prophylaxis (PrEP) and intermittent
antiretroviral pre-exposure prophylaxis (iPrEP) with ten-
ofovir (TDF) or Truvada (a combination of TDF and
emtricitabine) in non-human primates have shown a sig-
nificantly reduced risk of simian HIV (SHIV) infection
following rectal challenge [8-10].
TDF and Truvada are licensed for the treatment of HIV
infection and are generally well tolerated with few side
* Correspondence: fav1@cdc.gov
1 Thailand Ministry of Public Health - US Centers for Disease Control and 
Prevention Collaboration, Nonthaburi, Thailand
Full list of author information is available at the end of the articlevan Griensven et al. Journal of the International AIDS Society 2010, 13:13
http://www.jiasociety.org/content/13/1/13
Page 2 of 14
effects. TDF and Truvada are currently tested in Phase III
safety and efficacy trials of daily PrEP in injection drug
users, high-risk heterosexuals and MSM. A safety study
of daily TDF is being conducted simultaneously among
MSM in the United States [7,11]. Until these trials are
completed, the efficacy of any PrEP regimens, including
iPrEP, in preventing HIV infection is unknown.
Even though daily PrEP with Truvada may show effi-
cacy in preventing HIV infection in MSM, we do not
know whether daily intake of these drugs is required to
prevent infection. Given the long intracellular half-life of
TDF, antiretroviral activity may last for several days.
Recent animal studies have shown that intermittent pre-
and post-exposure prophylaxis with Truvada was effica-
cious in preventing SHIV infection following rectal expo-
sure [10]. Promising iPrEP regimens tested in these
studies included doses at two hours before and 22 hours
after exposure, 22 hours before and two hours after, and
72 hours before and two hours after [10].
Daily use of other prophylactic drugs, such as for
malaria and tuberculosis, has not been very successful.
Daily dosing of Truvada may be associated with toxicity
and mild side effects, such as cramping, diarrhea and flat-
ulence, which may interfere with adherence and thus with
protection. In addition, MSM may not be exposed to HIV
on a daily basis, unlike injection drug users or brothel-
based sex workers, and may therefore not be motivated to
take drugs daily.
Other prevention modalities for MSM, such as condom
use and post-exposure prophylaxis, are exposure driven
and intermittent. Anecdotal information suggests that
some high-risk MSM are using PrEP intermittently,
sometimes provided by their physicians. The available lit-
erature, however, suggests that this is an extremely rare
phenomenon [12,13].
In addition, the costs of daily PrEP may be financially
prohibitive, particularly for MSM in lower- and middle-
income countries. A recent analysis estimated that to
reduce the lifetime HIV infection risk for a gay man in the
United States from 44% to 25%, the per person cost of
daily PrEP was $151,600, on top of the $81,100 per person
already spent for regular prevention [14]. In a separate
analysis, the cost associated with a five-year daily prophy-
laxis programme for 15,000 MSM in the United States
was estimated at $900 million [15].
There are currently no studies evaluating the feasibility
of iPrEP for the prevention of HIV infection in MSM. For
example, we do not know how often MSM have sex and
are potentially exposed to HIV. If most MSM are exposed
on a daily basis, iPrEP is not a feasible prevention strat-
egy. It is also unknown to what extent MSM are planning
their sex. If the iPrEP regimen consists of a pre- and post-
exposure dose, MSM need to know when they are going
to have sex, in order to timely administer their pre-expo-
sure dose. Therefore, in this paper we report on the sex
frequency, sex planning and their predictive factors in a
cohort of HIV-negative MSM in Bangkok, Thailand.
Methods
Study population
Between April 2006 and December 2007, 1002 HIV-nega-
tive men enrolled in the Bangkok MSM Cohort Study, a
prospective study of HIV incidence, follow-up rates and
willingness to participate in HIV prevention trials. Men
w e r e  T h a i  n a t i o n a l s ,  r e s i d e n t s  o f  B a n g k o k,  a t  l e a s t  1 8
years old and had had penetrative sex with another man
in the past six months. At baseline, demographic and
behavioural data were collected using an audio-com-
puter-assisted self-interview.
In the cohort study, men were seen every four months
for HIV testing, medical history and behavioural assess-
ment for a duration of three years. Between February
2008 and May 2009, a cross-sectional substudy was con-
ducted in which 823 HIV-negative men completed an
audio-computer-assisted self-interview with questions
about how often they had sex and how often their sex was
planned.
The remaining 179 men (17.9%) were either lost to fol-
low up (n = 150) or seroconverted for HIV infection (n =
29) prior to taking the interview. Men who were lost to
follow up were significantly younger and less educated
than those who were retained in the study . Since HIV-
positive men are not eligible for PrEP, men who serocon-
verted for HIV infection were not included in this analy-
sis.
Measures
Questions in the interview included: (1) On the average,
how often do you have sex? (answering categories: every
day, several times a week, once a week, several times a
month, less than once a month); (2) On how many days
did you have sex in the past week? (0-7 days); (3) On what
days of the past week did you have sex? (Monday, Tuesday
... Sunday); and (4) Was the first sexual encounter on each
of those days planned or not? (yes/no). If no sex in the
past week was reported, participants were asked whether
the first sexual encounter on the last day they had had sex
was planned. "Planned sex" was defined as "having made
intentional arrangements to have sex, e.g., you went to
the park, sauna, bar or online to find a sex partner or you
had made an appointment with another man to have sex".
Statistical analysis
Descriptive statistics were used to characterize sex fre-
quency and sex planning; χ2 was used to compare the pro-
portion of respondents reporting sex on different days of
the week, while adjusting for multiple comparisons. Odds
ratios and 95% confidence intervals were used to evaluatevan Griensven et al. Journal of the International AIDS Society 2010, 13:13
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the association between demographic (at baseline) and
behavioural variables (during the four months preceding
the interview) and sex frequency and sex planning. Fac-
tors independently associated with sex frequency and sex
planning were identified by entering variables with P-val-
ues of less than 0.05 into backward stepwise logistic
r e g r e s s i o n  a n a l y s i s  ( S P S S  1 7 . 0 ,  S P S S  I n c .  C h i c a g o ,  I L ,
2008).
For the purpose of this analysis, sex frequency ("on how
m a n y  d a y s  i n  t h e  p a s t  w e e k  d i d  y o u  h a v e  s e x ? " )  w a s
dichotomized into sex on two days per week or less and
sex on three days per week or more; sex planning was
dichotomized into planned and unplanned based on
whether the first sex on the last day the participant
reported sex was planned or not. These cut-off points
were chosen based on their implications for iPrEP: if men
have sex on three days per week or more, the number of
pre- and post exposure doses will be almost equal or
exceed the number needed for daily PrEP. Hence daily
PrEP will be a more appropriate regimen for them; plan-
ning of the first sex on a day is necessary for a timely
administration of the pre-exposure dose. To retain all
subjects in the analysis, sex on the last day was chosen as
the dependent variable over a composite measure of
planned sex in the past week (since not all men reported
sex in the past week).
Ethical approval
The protocol of the current study was reviewed and
approved by the Ethical Review Committee of the Thai-
la nd Mi nis t ry of  P ubl ic H ea l t h a nd by  a n Ins ti t ut iona l
Review Board of the US Centers for Disease Control and
Prevention.
Results
Demographic and behavioural characteristics
The mean age of participants was 28.3 years (median 27
years, range 19-58 years), 50.4% had university education,
and 59.4% lived away from their families (Table 1). Dur-
ing the four months prior to enrolment, drug use was
reported by 8.9% and use of nitrate inhalers by 4.1%; no
participants reported to have injected drugs. Use of erec-
tile dysfunction drugs (ever) was reported by 5.3%. The
majority of participants (79.2%) identified as homosexual
and 37.7% said they were usually the insertive partner in
anal sex. Steady male sexual partner(s) were reported by
68.6% and male casual sexual partner(s) by 69.1%; always
u s i n g  a  c o n d o m  w i t h  m a l e  p a r t n e r s  w a s  r e p o r t e d  b y
43.7%.
Descriptive analysis of sex frequency and sex planning
When asked how many times men had sex on average,
1.3% said every day, 17.5% said several times a week and
the remaining 81.2% said once a week or less (Figure 1a).
When asked about how many days they had had sex in
the past week, 85.8% reported having had sex on two days
or less, and 14.2% reported having had sex on three days
or more (Figure 1b). Of the 522 men who reported sex in
the past week: 27.0% reported having it on Monday;
~23.0% on Tuesday, Wednesday or Thursday; 28.4% on
Friday; 32.6% on Saturday; and 33.1% Sunday (Figure 2a).
Sex on Saturday and Sunday was more often reported
than sex on Tuesday, Wednesday or Thursday (p < 0.001).
When asked whether the first sex on each of those days
was planned or unplanned, approximately 70% of first sex
on Saturday, Sunday and Monday was planned, whereas
60% to 65% of first sex on other weekdays was planned
(Figure 2b). There were no significant differences
between the percentages of planned sex on different days
of the week. During the past week, participants reported
1302 days on which they had had sex, of which the first
sex on 860 days (66.1%) was planned. When all partici-
pants (including those who did not report having sex in
the past week) were asked whether the first sex on the
most recent day they had sex was planned, 65.3%
answered affirmative.
Bivariate and multivariate analysis of sex frequency and sex 
planning
In bivariate analysis of sex frequency, use of alcohol,
drugs, erectile dysfunction drugs, having had casual part-
ner(s), group sex, sex with a foreigner, buying and selling
sex, and a history of HIV testing were associated with
having sex on three or more days of the past week. Demo-
graphic factors, other sexual variables, and condom use
were not associated with sex frequency (Table 1). In mul-
tivariate analysis, use of alcohol, erectile dysfunction
drugs, group sex, sex with a foreigner, buying and selling
sex, and a history of HIV testing were significantly and
independently associated with having sex on three or
more days of the week (Table 1).
In bivariate analysis of sex planning, being 22 to 29
years old, being unemployed, having lower education,
binge drinking, not identifying as homosexual, being at a
younger age at first anal sex, having receptive anal inter-
course, having sex once a month or less, and not engaging
in group sex were associated with unplanned sex (Table
2). In multivariate analysis, being at a younger age, not
identifying as homosexual, having receptive anal inter-
course, and not engaging in group sex were significantly
and independently associated with unplanned sex (Table
2).
Discussion
Most of the MSM enrolled in this study were exposed to
possible HIV infection only intermittently, and about
two-thirds of MSM had a window of opportunity to take
a pre-exposure dose of chemoprophylaxis prior to sexualvan Griensven et al. Journal of the International AIDS Society 2010, 13:13
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Table 1: Bivariate and multivariate analysis of having sex on three days or more per week among men who have sex with 
men in Bangkok, Thailand, 2009
Bivariate Multivariate
Demographics Total % Sex ≥ 3 
days
% OR 95% CI p OR 95% CI p
Total 823 100 117 14.2
Age group (years)
18-21 71 8.6 12 16.9 1.18 0.58-2.39 0.78
22-29 473 57.5 64 13.5 0.91 0.59-1.39 0.74
≥ 30 279 33.9 41 14.7 1
Employment
Yes 625 75.9 90 14.4 1.06 0.67-1.69 0.88
No 198 24.1 27 13.6 1
Education
Less than high school 56 6.8 6 10.7 1
High school or equivalent 352 42.8 58 16.5 1.64 0.67-4.01 0.37
University and above 415 50.4 53 12.8 1.22 0.49-2.98 0.82
Current living situation
Live with parents/relatives 334 40.6 37 11.1 1
Live with partner 104 12.6 19 18.3 1.79 0.98-3.28 0.08
Live alone/friend/other 385 46.8 61 15.8 1.51 0.98-2.34 0.08
Use of alcohol
(past 4 m)
Yes 660 80.2 107 16.2 2.96 1.51-5.80 0.001 2.49 1.24-4.98 0.01
No 163 19.6 10 6.1 1 1
Binge drinking
(past 4 m)*(n = 660)
Yes 76 11.5 17 22.4 1.58 0.88-2.84 0.17
No 584 88.5 90 15.4 1van Griensven et al. Journal of the International AIDS Society 2010, 13:13
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Use of any drugs
(past 4 m)
Yes 73 8.9 19 26.0 2.34 1.33-4.12 0.002 -†
No 750 91.1 98 13.1 1
Inhaled nitrites
(poppers) (past 4 m)
Yes 34 4.1 9 26.5 2.27 1.03-4.99 0.04 -†
No 789 95.9 108 13.7 1
Used club drugs‡
(past 4 m)
Yes 58 7.0 16 27.6 2.50 1.36-4.62 0.002 -†
No 765 93.0 101 13.2 1
Used erectile dysfunction drugs 
(ever)
Yes 43 5.2 18 41.9 4.95 2.61-9.41 <0.001 2.68 1.29-5.55 0.008
No 780 94.8 99 12.7 1 1
Sexual self identification (baseline)
Homosexual 652 79.2 93 14.3 1.02 0.63-1.65 0.94
Heterosexual/bisexual/Transgender 171 20.8 24 14.0 1
Age at first anal sex (n = 812)
≤ 15 115 14.2 21 18.3 1.40 0.83-2.35 0.26
> 15 697 85.8 96 13.8 1
Had steady male partner (past 4 m)
Yes 563 68.4 89 15.8 1.56 0.99-2.45 0.07
No 260 31.6 28 10.8 1
Had casual male partner (past 4 m)
Yes 568 69.0 95 16.7 2.13 1.30-3.47 0.002
No 255 31.0 22 8.6 1
Table 1: Bivariate and multivariate analysis of having sex on three days or more per week among men who have sex with 
men in Bangkok, Thailand, 2009 (Continued)van Griensven et al. Journal of the International AIDS Society 2010, 13:13
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Usual anal sex position with male 
(those who had anal sex) (n = 812)
Insertive 306 37.7 46 15.0 1.08 0.73-1.62 0.69
Receptive/both 506 62.3 71 14.0 1
Condom use with steady/casual 
male partners (past 4 m) (n = 771)
Always 435 56.4 58 13.3 1
Not always 336 43.6 57 17.0 1.33 0.89-1.97 0.19
Last sex was planned (n = 818)
Yes 534 65.3 79 14.8 1.12 0.74-1.71 0.58
No 284 34.7 38 13.4 1
Group sex (ever)
Yes 137 16.6 42 30.7 3.60 2.33-5.57 <0.001 2.07 1.27-3.36 0.003
No 686 83.4 75 10.9 1 1
Sex with foreigner
(past 4 m)
Yes 115 14.0 34 29.6 3.16 1.99-5.01 <0.001 1.84 1.11-3.06 0.02
No 708 86.0 83 11.7 1 1
Coerced into sex (ever)
Yes 144 17.5 20 13.9 1
No 679 82.5 97 14.3 1.03 0.61-1.74 0.90
Paid male partner for sex (past 4 m)
Yes 96 11.7 25 26.0 2.43 1.47-4.03 <0.001 1.91 1.10-3.30 0.02
No 727 88.3 92 12.7 1 1
Condom use with male partner you 
paid
(past 4 m) (n = 96)
Always 68 70.8 18 26.5 1.08 0.39-2.97 0.88
Not always 28 29.2 7 25.0 1
Table 1: Bivariate and multivariate analysis of having sex on three days or more per week among men who have sex with 
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Got paid for sex by male partner 
(past 4 m)
Yes 97 11.8 33 34.0 3.94 2.44-6.35 <0.001 2.68 1.59-4.52 <0.001
No 726 88.2 84 11.6 1 1
Condom use with male partner who 
paid you (past 4 m) (n = 97)
Always 77 79.4 28 36.4 1.71 0.56-5.21 0.49
Not always 20 20.6 5 25.0 1
Suicidal ideation§ (ever)
Yes 213 25.9 38 17.8 1.46 0.96-2.23 0.08
No 610 74.1 79 13.0 1
HIV testing (ever)
Yes 426 51.8 73 17.1 1.66 1.11-2.48 0.01 1.54 1.001-2.36 0.049
No 397 48.2 44 11.1 1 1
Worried about getting HIV 
infection
Never to regularly 587 71.3 77 13.1 1
Often to always 236 28.7 40 16.9 1.35 0.89-2.05 0.19
Worried about getting STI
Never to regularly 609 74.0 86 14.1 1
Often to always 214 26.0 31 14.5 1.03 0.66-1.61 0.99
Increased sexual risk behaviour 
after hearing about effective 
treatment for HIV infection
Not at all to moderate 645 78.4 97 15.0 1.40 0.84-2.34 0.24
Much to a great deal 178 21.6 20 11.2 1
*Got drunk 2-3 times per week or more in the past four months among those who used alcohol
†Dropped out of the multivariate model
‡Club drugs = marijuana, ecstasy, methamphetamine, ketamine, cocaine, and gamma hydroxy butyrate (GHB)
§Ever had seriously thought about or attempted suicide
M: month: STI: sexually transmitted infection
Table 1: Bivariate and multivariate analysis of having sex on three days or more per week among men who have sex with 
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activity. This information implies that in terms of fre-
quency of exposure, iPrEP may be a more appropriate
regimen than daily PrEP. Unfortunately, those lacking the
opportunity to take a timely pre-exposure dose were also
at high behavioural risk for HIV infection.
Factors in favour of iPrEP over daily PrEP include
reduced costs, decreased pill burden, and possibly,
reduced toxicity and drug side effects. Cost-effectiveness
analysis has shown that implementation of daily PrEP
would be extremely challenging, even in the developed
world [14,15]. In the developing world, where most of the
infections occur, daily PrEP would generally be not
affordable.
With respect to pill burden, daily intake of drugs for
considerable time in the absence of overt disease has
proven to be difficult for many people. Toxicity, in partic-
ular renal toxicity, and dysfunction have been reported in
association with TDF treatment [16]. Fewer doses of
drugs may reduce mild side effects, such as cramping,
diarrhea and flatulence, and may therefore positively
affect adherence.
As expected, sex was significantly more often reported
on the weekend, but differences with other days were
small. For those who almost exclusively have sex on the
weekend, this may provide an opportunity to develop pill-
taking routines, which may help to improve adherence.
With regard to sex planning, there were no significant
differences between the different days of the week. With
60% to 65% of the first sex on a day being planned, the
majority of men would principally be able to take pre-
Figure 1 Frequency of sex (a) and number of days in the past week on which sex was reported (b) among men who have sex with men in 
Bangkok, Thailand.
Figure 2 Days on which sex was reported in the past week (a) and planned first sex on a day (b) among men who have sex with men in 
Bangkok, Thailand.van Griensven et al. Journal of the International AIDS Society 2010, 13:13
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Table 2: Bivariate and multivariate analysis of unplanned sex among men who have sex with men in Bangkok, Thailand, 
2009
Bivariate Multivariate
Demographics Total % Unplan-ned sex % OR 95% CI p OR 95% CI p
Total 818 100 284 34.7
Age group (years)
18-21 70 8.6 32 45.7 2.41 1.40-4.14 0.002 1.71 0.89-3.28 0.11
22-29 470 57.5 180 38.3 1.78 1.28-2.46 0.001 1.67 1.12-2.48 0.01
≥30 278 34.0 72 25.9 1 1
Employment
Yes 621 75.9 203 32.7 1
No 197 24.1 81 41.1 1.44 1.03-1.99 0.04 -†
Education
Less than high school 56 6.8 31 55.4 3.13 1.77-5.52 <0.001 2.97 1.51-5.83 0.002
High school or 
equivalent
350 42.8 136 38.9 1.60 1.18-2.17 0.002 1.36 0.93-1.98 0.11





334 40.8 107 32.0 1
Live with partner 103 12.6 39 37.9 1.29 0.82-2.05 0.33
Live alone/friend/other 381 46.6 138 36.2 1.20 0.88-1.64 0.27
Use of alcohol
(past 4 m)
Yes 657 80.3 239 36.4 1.47 1.01-2.15 0.06
No 161 19.7 45 28.0 1
Binge drinking
(past 4 m)*(n = 657)
Yes 76 11.6 36 47.4 1.68 1.03-2.71 0.046 1.67 0.99-2.81 0.054
No 581 88.4 203 34.9 1 1van Griensven et al. Journal of the International AIDS Society 2010, 13:13
http://www.jiasociety.org/content/13/1/13
Page 10 of 14
Use of any drugs
(past 4 m)
Yes 73 8.9 28 38.4 1.19 0.72-1.95 0.58
No 745 91.1 256 34.4 1
Inhaled nitrates 
(poppers) (past 4 m)
Yes 34 4.2 8 23.5 1
No 784 95.8 276 35.2 1.77 0.79-3.95 0.22
Used club drugs‡ 
(past 4 m)
Yes 58 7.1 24 41.4 1.36 0.79-2.34 0.34




Yes 43 5.3 12 27.9 1




Homosexual 648 79.2 213 32.9 1 1
Heterosexual/bisexual/
transgender
170 20.8 71 41.8 1.46 1.04-2.07 0.04 1.58 1.04-2.38 0.03
Age at first anal sex (n 
= 807)
≤ 15 114 14.1 51 44.7 1.63 1.09-2.43 0.02 -†
> 15 693 85.9 230 33.2 1
Had steady male 
partner (past 4 m)
Yes 561 68.6 196 34.9 1.03 0.76-1.41 0.91
No 257 31.4 88 34.2 1
Table 2: Bivariate and multivariate analysis of unplanned sex among men who have sex with men in Bangkok, Thailand, 
2009 (Continued)van Griensven et al. Journal of the International AIDS Society 2010, 13:13
http://www.jiasociety.org/content/13/1/13
Page 11 of 14
Had casual male 
partner (past 4 m)
Yes 565 69.1 191 33.8 0.88 0.65-1.20 0.46
No 253 30.9 93 36.8 1
Usual anal sex position 
with male (those who 
had anal sex) (n = 807)
Insertive 306 37.9 87 28.4 1 1
Receptive/both 501 62.1 194 38.7 1.59 1.17-2.16 0.004 1.67 1.16-2.40 0.006
Condom use with 
steady/casual male 
partners (past 4 m) (n = 
768)
Always 433 56.4 140 32.3 1
Not always 335 43.6 127 37.9 1.28 0.95-1.72 0.12
Frequency of sex
Every day/several times 
per week
155 18.9 45 29.0 1
Once a week/several 
times per month
271 33.1 84 31.0 1.10 0.71-1.69 0.75 -†
Once a month or less 392 47.9 155 39.5 1.60 1.07-2.39 0.03
Group sex (ever)
Yes 137 16.7 34 24.8 1 1
No 681 83.3 250 36.7 1.76 1.16-2.67 0.01 1.84 1.17-2.91 0.009
Sex with foreigner
(past 4 m)
Yes 115 14.1 35 30.4 1
No 703 85.9 249 35.4 1.25 0.82-1.92 0.35
Coerced into sex (ever)
Yes 114 17.6 60 41.7 1.43 0.99-2.07 0.07
No 674 82.4 224 33.2 1
Table 2: Bivariate and multivariate analysis of unplanned sex among men who have sex with men in Bangkok, Thailand, 
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Paid male partner for 
sex (past 4 m)
Yes 96 11.7 33 34.4 1
No 722 88.3 251 34.8 1.02 0.65-1.59 1.00
Condom use with male 
partner you paid
(past 4 m) (n = 96)
Always 68 70.8 22 32.4 1
Not always 28 29.2 11 39.3 1.35 0.54-3.37 0.68
Got paid for sex by 
male partner (past 4 m)
Yes 96 11.7 36 37.5 1.15 0.74-1.78 0.62
No 722 88.3 248 34.3 1
Condom use with male 
partner who paid you 
(past 4 m) (n = 96)
Always 76 79.2 27 35.5 1
Not always 20 20.8 9 45.5 1.48 0.55-4.03 0.60
Suicidal ideation§ 
(ever)
Yes 212 25.9 84 39.6 1.33 0.96-1.84 0.10
No 606 74.1 200 33.0 1
HIV testing (ever)
Yes 425 52.0 140 32.9 1
No 393 48.0 144 36.9 1.18 0.88-1.57 0.30
Worried about getting 
HIV infection
Never to regularly 583 71.3 205 35.2 1.07 0.78-1.47 0.73
Often to always 235 28.7 79 33.6 1
Worried about getting 
STI
Table 2: Bivariate and multivariate analysis of unplanned sex among men who have sex with men in Bangkok, Thailand, 
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Never to regularly 605 74.0 211 34.9 1.03 0.74-1.43 0.94
Often to always 213 26.0 73 34.3 1
Increase sexual risk 
behaviour after 
hearing about 
effective treatment for 
HIV infection
Not at all to moderate 641 78.4 214 33.4 1
Much to a great deal 177 21.6 70 39.5 1.30 0.93-1.84 0.15
*Got drunk 2-3 times per week or more in the past four months among those who used alcohol
†Dropped out of the multivariate model
‡Club drugs = marijuana, ecstasy, methamphetamine, ketamine, cocaine, and gamma hydroxy butyrate (GHB)
§Ever had seriously thought about or attempted suicide
M: month: STI: sexually transmitted infection
Table 2: Bivariate and multivariate analysis of unplanned sex among men who have sex with men in Bangkok, Thailand, 
2009 (Continued)
exposure doses, but still, about one-third of men would
not. For these men, a regimen consisting of a number of
weekly standing doses followed by post-exposure doses
may be more appropriate in terms of opportunities for
adherence. We need to keep in mind, however, that in
these analyses, sex planning is used as a proxy for pill-tak-
ing behaviour, and that we do not know whether those
who plan their sex will also take their pre-exposure doses
as indicated.
Factors in our assessment that were independently and
significantly associated with more frequent sex were use
of alcohol, erectile dysfunction drugs, group sex, sex with
a foreigner, buying and selling sex, and a history of HIV
testing. Use of erectile dysfunction drugs, group sex, sex
with a foreigner, buying and selling sex, and a history of
HIV testing may be indicators of a more active sex life,
while alcohol use may be associated with decreased con-
trol over one's sexual behavior. Together, these factors
ma y help to identify those who should be targeted for
daily PrEP.
Being at a younger age, not identifying as homosexual,
having receptive anal intercourse, and not engaging in
group sex were independently and significantly associ-
ated with unplanned sex. Those who are younger and
those not engaging in group sex may be less likely or able
to plan their sex due to lack of experience or decreased
control over their sexual desire. Lack of control over part-
ner selection or the necessity to respond to sexual oppor-
tunities may explain the association between not
identifying as homosexual, receptive anal intercourse,
and unplanned sex.
The association between younger age, receptive anal
intercourse and unplanned sex is problematic, since the
former two are also known as risk factors for HIV infec-
tion [17]. Alternative PrEP regimens, such as two stand-
ing doses per week plus a post-exposure dose, if proven
efficacious, or other regimens or prevention methods,
may therefore be necessary for those who have
unplanned sex.
The results presented in this paper are subject to a
number of limitations. First of all, our data were collected
in a sample of men at high risk for HIV infection who
may not be representative of all MSM. Men at lower risk
may have different sex frequency and sex planning pro-
files. In addition, younger and less educated men were
more likely to have been lost to follow up in the current
study. Since both younger age and lower education were
found associated with unplanned sex, absence of these
men may have biased our results regarding sex planning
upwards.
Finally, our data are cross sectional and do not provide
information about changes in sex frequency and sex plan-
ning profiles over time. For the same reason, our risk fac-
tor analysis does not allow causal inference; for example,
it is unknown whether the risk factors occurred before or
after sexual frequency and sex planning profiles were
established.
Conclusions
Sexual behaviour profiles of MSM enrolled in this study
indicate that most men were exposed to HIV infection
only intermittently, and that most men had a window of
opportunity to take a pre-exposure dose prior to sexual
activity. This information implies that in terms of sex fre-
quency, iPrEP may be a more appropriate regimen than
daily PrEP. Unfortunately, those lacking the opportunity
to take a timely pre-exposure dose were at high behav-
ioural risk for HIV infection.van Griensven et al. Journal of the International AIDS Society 2010, 13:13
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Phase III trials of daily PrEP in humans are still ongoing
and it is unknown whether this regimen will be able to
prevent infection. iPrEP regimens discussed here (pre-
and post-exposure doses at different time intervals) have
not yet entered clinical evaluation in humans, but animal
studies are promising. Therefore, our data may help to
inform iPrEP regimens for evaluation in future clinical
trials in MSM.
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